Rebamipide

Home > API & Intermediate > Digestive System Drugs > Rebamipide Manufacturers > Rebamipide

Rebamipide

CAS NO.： 90098-04-7

FOB Price： NEGOTIABLE Get Latest Price

Specification： JPC/JP

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： 190MT/Year

Packing： 10KG/Fibre Drum

Product Detail

Properties

Rebamipide

CAS number: 90098-04-7

Molecular formula: C19H15ClN2O4

Molecular weight: 370.79

Product standard: JPC2002/JP15.2/JP16

Packaging and storage: 10kg/drum, inner packaging: two-layer polyethylene film bag, outer packaging: full paper drum.

Store at room temperature and airtight. The product re-inspection period is two years.

Properties

Rebapat is a new type of anti ulcer drug. It was first listed in Japan in 1990 as a drug for gastric ulcer and acute and chronic gastritis. Rebapat is a gastric mucosal protective agent, which can increase gastric mucosal blood flow, prostaglandin E2 synthesis and gastric mucus secretion, promote the expression of epidermal growth factor and its receptor, prevent ulcer occurrence and promote ulcer healing. Studies have shown that it is effective for various experimental gastric ulcers, can promote the production of prostaglandins in gastric mucosa, and protect gastric mucosa from various ulcer causing factors. It is suitable for the treatment of gastric ulcer, acute gastritis, acute exacerbation of chronic gastritis and gastric mucosal lesions. It has high clinical application value.

CAS No.

90098-04-7

Formula

C19H15ClN2O4

Molecular Mass

370.78600

Exact Mass

370.07200

PSA

99.26000

Logp

2.99810